Caris Life Sciences Inc - Class A

Research Caris Life Sciences Inc - Class A (CAI) on Bullrun: market cap USD 5.18B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCAI
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 5.18B
• Financial periodFY2025
• RevenueUSD 812.03M
• Revenue growth97.0%
• Net income-USD 68.09M
• Free cash flowUSD 66.90M

Valuation Snapshot

latest market cap is USD 5.18B.

About Caris Life Sciences Inc - Class A

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and artificial intelligence/machine learning algorithms. The company's molecular intelligence product portfolio includes MI Profile Platform, a whole exome sequencing (WES)/ whole transcriptome sequencing (WTS) tissue-based molecular profiling solutions;

Frequently asked questions

What is Caris Life Sciences Inc - Class A's market cap?

Caris Life Sciences Inc - Class A's market capitalization is USD 5.18B.

What does Caris Life Sciences Inc - Class A do?

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and artificial intelligence/machine learning algorithms.